Sulbactam Enhances in vitro Activity of β-Lactam Antibiotics Against Acinetobacter baumannii

Overview of attention for article published in Infection and Drug Resistance, September 2021

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 12 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 11 publications that cite this research output.

11

The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.

The Battle Against Antibiotic Resistance: Novel Therapeutic Options for Acinetobacter baumannii

Book chapter (November 2023)

Sulbactam-Durlobactam in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections

Article in Annals of Pharmacotherapy (October 2023)

Clinical outcomes and safety of intravenous polymyxin B-based treatment in critically ill patients with carbapenem-resistant Acinetobacter baumannii nosocomial pneumonia

Article in International Journal of Antimicrobial Agents (June 2023)